Copeptin is an independent predictor of diabetic heart disease and death.
Enhörning, Sofia LU ; Hedblad, Bo LU ; Nilsson, Peter LU ; Engström, Gunnar LU and Melander, Olle LU
(2015)
In American Heart Journal
169(4).
p.549-549
- Abstract
- We previously discovered that high copeptin is associated with incidence of diabetes mellitus (diabetes), abdominal obesity, and albuminuria. Furthermore, copeptin predicts cardiovascular events after myocardial infarction in diabetic patients, but whether it is associated with heart disease and death in individuals without diabetes and prevalent cardiovascular disease is unknown. In this study, we aim to test whether plasma copeptin (copeptin), the C-terminal fragment of arginine vasopressin prohormone, predicts heart disease and death differentially in diabetic and nondiabetic individuals.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5257338
- author
- Enhörning, Sofia
LU
; Hedblad, Bo
LU
; Nilsson, Peter
LU
; Engström, Gunnar
LU
and Melander, Olle
LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- American Heart Journal
- volume
- 169
- issue
- 4
- pages
- 549 - 549
- publisher
- Mosby-Elsevier
- external identifiers
-
- pmid:25819862
- wos:000351949500018
- scopus:84927570940
- pmid:25819862
- ISSN
- 1097-6744
- DOI
- 10.1016/j.ahj.2014.11.020
- language
- English
- LU publication?
- yes
- id
- efcc3a0c-0dec-4a31-88ed-a02beca84dd3 (old id 5257338)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25819862?dopt=Abstract
- date added to LUP
- 2016-04-01 11:16:42
- date last changed
- 2024-01-07 11:53:46
@article{efcc3a0c-0dec-4a31-88ed-a02beca84dd3,
abstract = {{We previously discovered that high copeptin is associated with incidence of diabetes mellitus (diabetes), abdominal obesity, and albuminuria. Furthermore, copeptin predicts cardiovascular events after myocardial infarction in diabetic patients, but whether it is associated with heart disease and death in individuals without diabetes and prevalent cardiovascular disease is unknown. In this study, we aim to test whether plasma copeptin (copeptin), the C-terminal fragment of arginine vasopressin prohormone, predicts heart disease and death differentially in diabetic and nondiabetic individuals.}},
author = {{Enhörning, Sofia and Hedblad, Bo and Nilsson, Peter and Engström, Gunnar and Melander, Olle}},
issn = {{1097-6744}},
language = {{eng}},
number = {{4}},
pages = {{549--549}},
publisher = {{Mosby-Elsevier}},
series = {{American Heart Journal}},
title = {{Copeptin is an independent predictor of diabetic heart disease and death.}},
url = {{http://dx.doi.org/10.1016/j.ahj.2014.11.020}},
doi = {{10.1016/j.ahj.2014.11.020}},
volume = {{169}},
year = {{2015}},
}